60 Degrees Pharmaceuticals, Inc.
SXTPNasdaqCIK 1946563HealthcareFiscal year ends Dec 31
Reports and events: 77 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-07-1617:28 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-061853 |
| 2024-07-0915:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-060093 |
| 2024-06-2717:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-056728 |
| 2024-06-1217:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-052167 |
| 2024-05-3014:15 ET | DEF 14A | Proxy statementPeriod 2024-07-16 | 0001213900-24-047861 |
| 2024-05-1511:56 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-043323 |
| 2024-05-0216:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-039151 |
| 2024-04-0114:32 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-028577 |
| 2024-03-1519:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-022736 |
| 2024-02-2819:01 ET | 8-K | 3.01 Delisting notice | 0001213900-24-017634 |
| 2024-02-2016:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-015295 |
| 2024-02-0217:37 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001575872-24-000114 |
| 2024-01-2217:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-005352 |
| 2024-01-2215:57 ET | S-1 | Registration statement | 0001213900-24-005285 |
| 2024-01-1614:56 ET | 8-K | 8.01 Other events | 0001213900-24-003691 |
| 2023-11-2012:41 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-088610 |
| 2023-11-0316:15 ET | 8-K | 3.01 Delisting notice | 0001213900-23-083513 |
| 2023-10-1216:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-23-003541 |
| 2023-09-1816:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-077357 |
| 2023-08-2515:26 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-070884 |
| 2023-07-1716:08 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001575872-23-001173 |
| 2023-06-0816:56 ET | S-1/A | Registration statement, amended | 0001575872-23-000911 |
| 2023-06-0114:53 ET | S-1/A | Registration statement, amended | 0001575872-23-000882 |
| 2023-05-1915:13 ET | S-1/A | Registration statement, amended | 0001575872-23-000790 |
| 2023-04-2816:47 ET | S-1/A | Registration statement, amended | 0001575872-23-000644 |
| 2023-04-0317:11 ET | S-1/A | Registration statement, amended | 0001575872-23-000507 |
| 2023-01-3117:09 ET | S-1 | Registration statement | 0001575872-23-000186 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.